Each year, scientists create an influenza (flu) vaccine that protects against a few specific influenza strains that researchers predict are going to be the most common during that year. Now, a new study shows that scientists may be able to create a ‘universal’ vaccine that can provide broad protection against numerous influenza strains, including those that could cause future pandemics.
The study appears in mBio, the online open-access journal of the American Society for Microbiology.
“The reason researchers change the vaccine every year is that they want to specifically match the vaccine to the particular viruses that are circulating, such as H1N1. If the vaccine is just a little bit different to the target virus, it is not expected to offer much protection,” said principal investigator of the study Jeffery Taubenberger, MD, PhD, Chief of Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID). “What we have done is design a strategy where you don’t have to think about matching the vaccine antigen to the virus at all.”
In the new study, researchers at the NIAID used a virus-like particle vaccine cocktail that expressed a handful of different subtypes of a key surface protein of the influenza virus: hemagglutinin H1, H3, H5 and H7. “There are 16 different hemagglutinin subtypes that circulate in birds and are thought to be the basis for current and future influenza pandemics,” said Dr. Taubenberger. “The hypothesis was that the presentation of these different viral proteins would stimulate the development of cross-protective immunity that would provide broader protection against multiple subtypes.”
The researchers picked the H1 and H3 subtypes because they have been the major cause of human seasonal flu outbreaks since 1918. They chose the H5 and H7 subtypes because they have been the cause of recent bird flu outbreaks and have pandemic potential. This selection also provided a broad representation of hemagglutinins across the phylogenetic tree.
In a series of experiments, the researchers found that 95% of mice vaccinated with the investigational cocktail were protected against a lethal challenge with eight different influenza strains expressing seven different influenza A subtypes, compared to only 5% of mice who received mock vaccinations.
“Almost all of the animals that were vaccinated survived, including mice that were challenged with viruses that expressed hemagglutinin subtypes that were not in the vaccine at all, viruses that expressed H2, H6, H10, and H11,” said Dr. Taubenberger. “What that suggests is that this approach really gives us broad spectrum protection, and could serve as a basis for an effective pre-pandemic vaccine.”
Additional experiments showed that the vaccine was durable, effective for at least 6 months, and that it worked well in older mice. This is important given that elderly people are particularly susceptible to severe disease following influenza infection, and current vaccines are less efficacious in the elderly than in younger people.
“These initial findings are very positive and suggest a promising and practical strategy for developing a vaccine with amazing, broad protection,” said Dr. Taubenberger.
Read more: UNIVERSAL FLU VACCINE IN THE WORKS
The Latest on: Universal Flu Vaccine
via Google News
The Latest on: Universal Flu Vaccine
- Researchers Begin Testing Long-Term ‘Universal’ Flu Vaccine on April 18, 2019 at 2:25 pm
After peaking in mid-February, flu rates are on the decline across the state of Texas following a relatively mild season compared to last year, according to the Department of State Health Services. […]
- UW researchers developing permanent flu vaccine score $45M donation on April 17, 2019 at 12:49 pm
That includes a project in development to create a universal flu vaccine that provides permanent immunity from the illness. That in turn, could even break the door wide open for research on ... […]
- UW institute developing lifetime flu vaccine gets $45 million award on April 16, 2019 at 5:13 pm
A universal flu vaccine that immunizes someone for a lifetime. Smart proteins that can identify cancerous cells. Nanomaterial proteins that self-assemble and could be used for solar energy. These are ... […]
- First-In-Human Trial Begins On Universal Flu Vaccine, Older Adults Still Encouraged To Vaccinate on April 16, 2019 at 7:20 am
As researchers at the National Institutes of Health (NIH) begin clinical trials on a “universal” flu vaccine this month, older adults are reminded that immunizations aren’t just for children anymore. ... […]
- BiondVax Universal Flu Vaccine Patent Application Accepted in Australia on April 15, 2019 at 4:50 am
JERUSALEM, April 15, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), announced today that a patent application covering formulation and production processes of the M-001 universal ... […]
- Three more die in Cuyahoga County as flu season extends to spring; universal flu shot being tested on April 10, 2019 at 12:41 pm
More than 50,000 deaths due to influenza have been recorded nationally, according to the CDC. In the future, health providers may be able to offer a universal flu vaccine that gives protection for ... […]
- Experimental ‘Universal’ Influenza Vaccine Being Evaluated in Healthy Volunteers on April 8, 2019 at 9:52 am
A healthy volunteer receives an experimental universal influenza vaccine known as H1ssF_3928 (Image: National Institute of Allergy and Infectious Diseases) The National Institutes of Health (NIH) has ... […]
- Scientists review influenza vaccine research progress and opportunities on April 8, 2019 at 7:40 am
In a new series of articles, experts in immunology, virology, epidemiology, and vaccine development detail efforts to improve seasonal influenza vaccines and ultimately develop a universal influenza ... […]
- First Human Trial of Universal Flu Vaccine Underway on April 7, 2019 at 7:29 am
Researchers are conducting the first-in-human trial of a universal influenza vaccine candidate, the National Institutes of Health (NIH) announced April 3. The NIH's National Institute of Allergy and ... […]
- Scientists begin first human trial for universal flu vaccine on April 5, 2019 at 6:12 pm
BETHESDA, MD. — Scientists at the National Institute of Allergy and Infectious Diseases have started their first human trial for a universal influenza vaccine. According to a press release, the ... […]
via Bing News